Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Harpoon Therapeutics

Harpoon Therapeutics
2015 FOUNDED
PUBLIC STATUS
51-60 EMPLOYEES
HARP STOCK SYMBOL
$13.81 SHARE PRICE (As of Wednesday Closing)
Description

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 4000 Shoreline Court
  • Suite 250
  • South San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Harpoon Therapeutics’s full profile, request a free trial.

Harpoon Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$9.07 - $21.47 $340M $14.14 -$2.98 113K 24.6M

Harpoon Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 216,898
Revenue 4,604 4,750 708 0
EBITDA (52,729) (27,117) (16,257) (10,953)
Net Income (51,036) (27,366) (16,830) (11,406)
Total Assets 142,388 102,580 31,872 8,384
Total Debt 15,038 0 0 2,312
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Harpoon Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Harpoon Therapeutics‘s full profile, request access.

Request full access to PitchBook

Harpoon Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Harpoon Therapeutics‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Harpoon Therapeutics Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jounce Therapeutics Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
00000 00000000000 Formerly VC-backed Hayward, CA 000 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Harpoon Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Harpoon Therapeutics‘s full profile, request access.

Request full access to PitchBook

Harpoon Therapeutics Executive Team (7)

Name Title Board
Seat
Contact
Info
Gerald McMahon Ph.D Chief Executive Officer & Board Member
Georgia Erbez Chief Financial Officer
Holger Wesche Chief Scientific Officer
Che-Leung Law Ph.D Vice President of Translational Medicine
Natalie Sacks MD Chief Medical Officer

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Harpoon Therapeutics Board Members (9)

Name Representing Role Since Contact
Info
Gerald McMahon Ph.D Harpoon Therapeutics Chief Executive Officer & Board Member 000 0000
Jonathan Drachman MD Self Board Member 000 0000
Julie Eastland Self Board Member 000 0000
Luke Evnin Ph.D Self Chairman & Founder 000 0000
Mark Chin Arix Bioscience Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »